CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Clinical trials for CLEAR CELL RENAL CELL CARCINOMA (CCRCC) explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL RENAL CELL CARCINOMA (CCRCC) trials appear
Sign up with your email to follow new studies for CLEAR CELL RENAL CELL CARCINOMA (CCRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug KO-2806 enters first human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called KO-2806 in adults with advanced solid tumors that have not responded to standard treatments. The study aims to find safe doses and see if the drug can shrink tumors when used alone or with other cancer medicines. About 300 participan…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated May 26, 2026 11:45 UTC
-
New drug combo hopes to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests an experimental drug, REGN10597, alone or with another drug (cemiplimab) in people with advanced solid tumors like melanoma and kidney cancer. The main goals are to check safety, find the right dose, and see if the drugs can shrink tumors. About 240 a…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 11:42 UTC
-
New hope for kidney cancer: triple-drug combo enters phase 2 trial
Disease control Recruiting nowThis study tests three different drug combinations in 120 people with advanced kidney cancer that has spread. One group gets a new two-drug combo (fianlimab and cemiplimab), another adds a third drug (ipilimumab), and the third gets the current standard treatment. The goal is to …
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Phase: PHASE2 • Sponsor: Brian Rini • Aim: Disease control
Last updated May 26, 2026 11:37 UTC
-
New drug cocktail aims to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called XL092, alone or with other immune-boosting drugs, in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to find safe doses and see if the combination can shrink tumors or slow their gro…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Phase: PHASE1 • Sponsor: Exelixis • Aim: Disease control
Last updated May 19, 2026 11:46 UTC
-
New drug combo aims to shrink tough prostate tumors
Disease control Recruiting nowThis study tests a new drug, REGN5678, alone or with another drug (cemiplimab) in people with advanced prostate cancer that no longer responds to hormone therapy. The goal is to find safe doses and see if the drugs can shrink tumors by helping the immune system attack cancer cell…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 19, 2026 11:46 UTC
-
Drug combo may help save kidneys in High-Risk cancer patients
Disease control Recruiting nowThis study tests whether giving two drugs (pucotenlimab and vorolanib) before surgery can shrink kidney tumors enough to allow partial kidney removal instead of full removal. About 21 adults with high-risk clear cell renal cell carcinoma will receive the drug combination for seve…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 18, 2026 11:59 UTC